
TLSA
Healthcare · Biotechnology · $72.5M market cap
$0.5699-0.04 (-6.7%)Nov 13, 4:00 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Mar 31, 2023
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 3, 2025 | Time not confirmed | — | -0.05 | — |
| Jun 23, 2025 | After the close | — | -0.07 | — |
| Oct 18, 2024 | Time not confirmed | — | -0.05 | — |
| Dec 27, 2022 | After the close | 0.00 | -0.06 | — |
| May 22, 2022 | After the close | -0.06 | -0.06 | 0.0% |
| Dec 1, 2021 | Time not confirmed | — | 0.00 | — |
| Sep 24, 2021 | After the close | 0.00 | -0.08 | — |
| May 17, 2021 | After the close | -0.04 | -0.06 | -42.7% |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.06 | — |
| Dec 2, 2020 | Time not confirmed | -0.04 | -0.04 | 0.0% |
| Sep 30, 2020 | Before the open | -0.01 | -0.04 | -296.0% |
| Jun 17, 2020 | After the close | -0.25 | -0.04 | +84.2% |
| Mar 31, 2020 | Time not confirmed | 0.00 | -0.02 | — |
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system…
| Nov 27, 2019 | Time not confirmed | -0.14 | -0.14 | 0.0% |
| Sep 30, 2019 | Before the open | -0.04 | -0.12 | -200.0% |
| Apr 4, 2019 | Before the open | -0.01 | -0.03 | -236.0% |
| Mar 31, 2019 | Time not confirmed | 0.00 | -0.02 | — |
| Nov 21, 2018 | After the close | 0.00 | -0.01 | — |
| Sep 24, 2018 | Time not confirmed | — | -0.10 | — |
| Jun 30, 2018 | Time not confirmed | 0.00 | -0.02 | — |
| Mar 31, 2018 | Time not confirmed | 0.00 | -0.02 | — |